###begin article-title 0
###xml 123 126 <span type="species:ncbi:10116">Rat</span>
Changes in Glial Cell Line-derived Neurotrophic Factor Expression in the Rostral and Caudal Stumps of the Transected Adult Rat Spinal Cord
###end article-title 0
###begin p 1
###xml 278 279 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink">9</sub>
###xml 281 283 281 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 294 298 <span type="species:ncbi:10116">rats</span>
###xml 606 610 <span type="species:ncbi:10116">rats</span>
###xml 1622 1626 <span type="species:ncbi:10116">rats</span>
Limited information is available regarding the role of endogenous Glial cell line-derived neurotrophic factor (GDNF) in the spinal cord following transection injury. The present study investigated the possible role of GDNF in injured spinal cords following transection injury (T9-T10) in adult rats. The locomotor function recovery of animals by the BBB (Basso, Beattie, Bresnahan) scale score showed that hindlimb support and stepping function increased gradually from 7 days post operation (dpo) to 21 dpo. However, the locomotion function in the hindlimbs decreased effectively in GDNF-antibody treated rats. GDNF immunoreactivty in neurons in the ventral horn of the rostral stump was stained strongly at 3 and 7 dpo, and in the caudal stump at 14 dpo, while immunostaining in astrocytes was also seen at all time-points after transection injury. Western blot showed that the level of GDNF protein underwent a rapid decrease at 7 dpo in both stumps, and was followed by a partial recovery at a later time-point, when compared with the sham-operated group. GDNF mRNA-positive signals were detected in neurons of the ventral horn, especially in lamina IX. No regenerative fibers from corticospinal tract can be seen in the caudal segment near the injury site using BDA tracing technique. No somatosensory evoked potentials (SEP) could be recorded throughout the experimental period as well. These findings suggested that intrinsic GDNF in the spinal cord could play an essential role in neuroplasticity. The mechanism may be that GDNF is involved in the regulation of local circuitry in transected spinal cords of adult rats.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 222 229 <span type="species:ncbi:9606">persons</span>
Spinal cord injury (SCI), a common result of car accidents, high-altitude falls and crashes, and other violent injuries is increasing yearly. It has been reported that there are about 15-40 traumatic SCI cases per million persons annually population worldwide [1]. Once the spinal cord is damaged, it usually results in severe neurologic dysfunction and disability. Over the past several years, many extensive experiments have been done in order to find a way to promote the repair of the injured spinal cord. However, no good therapeutic approaches have yet been found. Recently, it has been shown that delivery of exogenous neurotrophic factors (NTFs) to the injured spinal cord has beneficial effects in improving functional recovery [2], indicating the potential value of NTFs in the treatment of SCI.
###end p 4
###begin p 5
###xml 286 287 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 572 573 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 574 576 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 714 716 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 753 755 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 837 839 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 958 960 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 962 964 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 966 968 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1097 1099 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 1101 1103 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 1230 1232 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 1233 1235 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 1510 1511 1496 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 1513 1515 1499 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1516 1518 1502 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 820 823 <span type="species:ncbi:10116">rat</span>
Glial cell line-derived neurotrophic factor (GDNF), a distant member of the transforming growth factor-beta (TGF-beta) family, was originally purified using an assay based on its ability to maintain the survival and function of embryonic ventral midbrain dopaminergic neurons in vitro [3]. GDNF supports neural survival in several neuronal populations, including midbrain dopamine neurons and motoneurons in the central nervous system. It promotes the survival and the differentiation of many peripheral neurons, such as sympathetic, parasympathetic, and sensory neurons [3-10]. Following injury, GDNF showed a benefit effect to rescue motoneurons degeneration after spinal root avulsion and distal nerve axotomy [11], promotion of axonal regeneration [12] and enhancing regeneration of dorsal roots (DR) into the adult rat spinal cord [13]. In addition, the transplantation of GDNF-producing cells greatly enhances the survival of spinal cord motorneurons [11, 14, 15] and regeneration of several spinal systems, including dorsal column sensory, and regionally projecting propriospinal pathways [16, 17] after SCI. The biological action of GDNF is mediated by a two-component receptor GFRalpha-1 and protein tyrosine kinase Ret [18-21]. The GFRalpha-1 receptors expressed on a variety of neurons that project into the spinal cord, including supraspinal neurons, dorsal root ganglia, and local neurons. GDNF mRNAs are widely distributed in a variety of neuronal and non-neuronal tissues of embryos and adults [4, 22-25].
###end p 5
###begin p 6
###xml 343 347 <span type="species:ncbi:10116">rats</span>
Although exogenous GDNF is available partially to promote propriospinal axonal regeneration and locomotion functional recovery, the role of intrinsic GDNF in injured spinal cords is largely unknown. Therefore, the present study investigated the possible role of GDNF at various time intervals following spinal cord transection injury in adult rats, so as to gain insights into the contribution of endogenous GDNF in spinal neuroplasticity.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
Characterization of antibodies
###end title 8
###begin p 9
###xml 66 72 <span type="species:ncbi:9986">rabbit</span>
###xml 245 248 <span type="species:ncbi:10116">rat</span>
To localize GDNF protein in the spinal cord, an affinity-purified rabbit polyclonal antibody (D-20, Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used in this study. The specificity of antibody for GDNF was confirmed by Western blots using rat spinal cord homogenates.
###end p 9
###begin title 10
Preparation of probe for in situ hybridization
###end title 10
###begin p 11
###xml 171 175 <span type="species:ncbi:10116">rats</span>
For detection of GDNF cellular expression in situ, we used Digoxigenin-labeled oligonucleotide probe designed by Primer premier 5.0 package which was complementary to the rats GDNF gene sequence (33 mer, 5'-GCCCTACTTTGTCAC-TCACCAGCCTTCTATTTC-3'). This antisense DNA single-stranded oligonucleotide probe was synthesized by Takara Biotechnology Company.
###end p 11
###begin title 12
Animal grouping and surgery
###end title 12
###begin p 13
###xml 403 404 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 452 453 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1219 1220 1219 1220 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1222 1223 1222 1223 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8</sub>
###xml 1311 1312 1311 1312 <sub xmlns:xlink="http://www.w3.org/1999/xlink">9</sub>
###xml 1314 1316 1314 1316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 1357 1359 1357 1359 <sub xmlns:xlink="http://www.w3.org/1999/xlink">9 </sub>
###xml 1364 1366 1364 1366 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 17 36 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 169 173 <span type="species:ncbi:10116">rats</span>
###xml 500 504 <span type="species:ncbi:10116">rats</span>
###xml 776 780 <span type="species:ncbi:10116">rats</span>
###xml 1105 1109 <span type="species:ncbi:10116">rats</span>
Sixty-five adult Sprague-Dawley rats of either sex (weighing 200-220 g) were obtained from the Animal Experiment Center of Sichuan University of Medical Sciences. Fifty rats among all animals, designated as sham-operated group and spinal cord transection group that animals were allowed to survive 3, 7, 14 and 21 days post operation (dpo), were used for immunohistochemistry and in situ hybridization (n = 5 in each group), and Western blot analysis (n = 5 in each group) respectively. Another five rats were intraperitoneally injected anti-GDNF solution (2.5 ml/kg) once every 2 days until 21 dpo, designed as antibody neutralization group. Five animals, subjected to cord transaction, were injected with distilled water as the distilled water group. The last five operated rats were used to investigate corticospinal tract sprouting. Every effort was taken to reduce the number of animals and suffering during the experiments. All the experiments using animals were carried out according to the guidelines of the NIH Guide for Care and Use of Laboratory Animal. For the cord transection operation, the rats were anesthetized with 3.6% Chloral Hydrate (1 ml/100 g). A midline incision was made in the back, then the T7-T8 spinous processes and the vertebral laminae were removed to expose the spinal cord at T9-T10 level. The cord was transected between T9 and T10 segments with a pair of microscissors. After surgery, the superficial back muscles and the skin were sutured along the midline.
###end p 13
###begin title 14
Behavior tests
###end title 14
###begin p 15
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 4 8 <span type="species:ncbi:10116">rats</span>
All rats in each group were evaluated using the BBB (Basso, Beattie, Bresnahan) scale score [26]. The BBB score for evaluation of hindlimbs function after transected injury ranges from zero, which corresponds to flaccid paralysis, to 21, which is normal gait. Animals were allowed to walk around freely in a circular field (1.2 m in diameter) for 4 min while movements of the hindlimbs were closely observed. Ranking according to the scoring system described by Basso et al. [26] includes frequency and quality of hindlimb movement as well as forelimb/hindlimb coordination.
###end p 15
###begin title 16
Measurement of somatosensory evoked potentials (SEP)
###end title 16
###begin p 17
###xml 32 36 <span type="species:ncbi:10116">rats</span>
The right peroneal nerve of the rats was dissected and a stimulation electrode was placed on it while a hole (3-4 mm in diameter) was made on the skull (2 mm to the left of the midline and 2 mm in front of the fonticulus posterior). An electrode was placed on the dura of brain cortex to record the SEP. The reference electrode was inserted at the nose epithelium. A ground electrode was inserted at the tail. The stimulus intensity was set high enough to produce a marked muscle twitch in the hind limb, about 1.1 mA, the amplitude was 0.2 ms and the frequency 3 Hz. The SEP Tracings represented the average of 200 responses.
###end p 17
###begin title 18
Immunohistochemistry
###end title 18
###begin p 19
###xml 200 201 200 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">9</sub>
###xml 207 209 207 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 633 634 632 633 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 635 636 634 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1230 1231 1223 1224 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1232 1234 1225 1227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 57 61 <span type="species:ncbi:10116">rats</span>
###xml 754 758 <span type="species:ncbi:9925">goat</span>
###xml 896 902 <span type="species:ncbi:9986">rabbit</span>
###xml 966 970 <span type="species:ncbi:9925">goat</span>
###xml 976 982 <span type="species:ncbi:9986">rabbit</span>
After anesthesia with 3.6% Chloral Hydrate (1 ml/100 g), rats were perfused with 500 ml of cold phosphate-buffered saline (PBS) for 5 min and 500 ml cold 4% paraformaldehyde solution for 30 min. The T9 and T10 spinal cord segments in the sham-operated group, and the cord stumps rostral and caudal to the injury site in the experimental group were harvested. This was followed by a postfix for 6-12 h, then immersed in 0.1 M PBS containing 20% sucrose overnight. Sections of 20 mum thickness were cut on a freezing microtome and used for freefloating GDNF immunostaining, then rinsed with 0.01 M PBS and soaked in PBS containing 3% H2O2 for 30 min at room temperature to quench the endogenous peroxidase activity. They were immersed in PBS containing 5% goat serum and 0.3% TritonX-100 solution at room temperature for 2 h, then incubated at 4degreesC for 24 h with anti-GDNF (1:1,000, Chemicon) rabbit polyclonal antibody. Sections were incubated with biotinylated goat anti-rabbit IgG antibody (1:100 dilution) for 1.5 h at room temperature, and by reaction with avidin-biotinylated peroxidase complexes (1:250, ABC Elite, Vector Labs). GDNF immunoreactivity was visualized with brown staining using diaminobenzidine (DAB) and H2O2 as substrate for 5 min, and observed with a light microscope. Negative control experiments in which PBS was substituted for the primary antibody were performed to ascertain the specificity of antibody staining.
###end p 19
###begin title 20
In situ hybridization
###end title 20
###begin p 21
###xml 28 32 <span type="species:ncbi:10116">rats</span>
###xml 1352 1357 <span type="species:ncbi:9940">sheep</span>
Sections from sham-operated rats of 25 mum thickness were also cut on a freezing microtome and used for in situ hybridization. Sections were fixed in 4% paraformaldehyde in 0.1 M PBS, pH 7.2 (all treatments were performed at room temperature unless otherwise indicated), and further treated with 0.3% TritonX-100 solution for 10 min and proteinase K (5 mug/ml) at 37degreesC for 25 min, refixed with 4% paraformaldehyde for 5 min, repeatedly immersed in 0.1 M PBS, then acetylated with 0.25% acetic anhydride in 0.1 M triethanolamine (pH 8.0) to prevent non-specific binding of the probes. The sections were washed with 2x SSC (pH 7.0) and then prehybridized in a hybridization solution (50% formamide, 10% dextran sulfate, 1x Denhardt's solution, 0.2 mg/ml Herring sperm DNA, and 10 mM dithiothreitol) without probes at 37degreesC for 2 h before hybridization, then hybridized in 100 mul hybridization solution containing 1 mul probes at 37degreesC for 12-16 h in a moist chamber. This was followed by washing in decreasing concentrations of SSC, from 4x SSC (pH 7.0) at 37degreesC for 20 min, 2x SSC (pH 7.0) at 42degreesC for 20 min, 1x SSC (pH 7.0) at 48degreesC for 20 min and ending with 0.5x SSC (pH 7.0) at 50degreesC for 20 min. Then sections were incubated at 37degreesC in 1% blocking buffer (Roche) for 1 h, subsequently reacted in 1:1,000 sheep anti-digoxygenin-alkaline phosphatase (AP) antibody in 1% blocking buffer at 4degreesC overnight. Lastly, AP activity was detected using nitroblue tetrazolium (NBT)/5-bromo-4-chloro-3-indolyl phosphate (BCIP) substrate (Roche). The sections were visualized with blue and purple sedimentation then observed with a light microscope.
###end p 21
###begin title 22
GFAP/GDNF double-label immunohistochemistry
###end title 22
###begin p 23
###xml 204 210 <span type="species:ncbi:9986">rabbit</span>
###xml 336 342 <span type="species:ncbi:9986">rabbit</span>
Two-color immunohistochemical staining for simultaneous detection of glial fibrillary acidic protein (GFAP)/GDNF expression was performed as described above. Briefly, sections were stained with anti-GDNF rabbit polyclonal antibody (1:1,000), and using DAB solutions as a substrate. This was followed by second incubation with anti-GFAP rabbit polyclonal antibody (1:1,000, AB5804, Chemicon), and finally, reacted with TMB solutions. Double labeling showed a combination of brown and blue product.
###end p 23
###begin title 24
Western blotting
###end title 24
###begin p 25
###xml 341 342 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1050 1054 <span type="species:ncbi:9925">goat</span>
###xml 1060 1066 <span type="species:ncbi:9986">rabbit</span>
The spinal cord from the rostral and caudal stumps was obtained. After carefully removing the spinal meninges, the cords were homogenized on ice in a Lysis Buffer containing 0.05 M Tris-HCl (pH 7.4, Amresco), 0.5 M EDTA (Amresco), 30% TritonX-100 (Amresco), NaCl (Amresco), 10% SDS (Sigma) and 1 mM PMSF (Amresco), then centrifuged at 12,000g for 30 min. The supernatant was obtained and stored at -80degreesC for late use. Protein concentration was assayed with BCA reagent (Sigma, St. Louis, MO, USA). A 20 mul aliquot of the samples was loaded on to each lane and electrophoresed on 12% SDS-polyacrylamide gel (SDS-PAGE) for 2.5 h at a constant voltage of 120 V. Proteins were transferred from the gel to a nitrocellulose membrane for 435 min at 24 V. The membrane was blocked with phosphate-buffered saline containing 0.05% Tween-20 (PBST) with 10% non-fat dry milk overnight at 4degreesC. The membrane was rinsed with PBST and incubated with the primary antibody for GDNF (1:1,000) at 4degreesC. The membrane was incubated with a HRP-conjugated goat anti-rabbit IgG (1:5,000; Vector Laboratories, CA) for 2 h at room temperature. The membrane was developed in ECM kit and exposed against X-ray film in a darkroom. Densitometry analysis for the level of GDNF protein was performed by Bio-Gel Imagining system equipped with Genius synaptic gene tool software. beta-actin (the primary antibody, 1:1,000, the secondary antibody, 1:2,000; Santa Cruz Biotechnology) was used as an internal control.
###end p 25
###begin title 26
BDA anterograde tracing
###end title 26
###begin p 27
At 14 dpo, the animals for this part were anesthetized and fixed in a David Kopf Instruments (Tujunga, CA) stereotaxic head-holder device. Burr holes were made in the dorsal cranium, and biotinylated dextran amine (BDA) (10% BDA solution, Molecular Probes) was microinjected into eight sites at a depth of 0.7 mm from the cortical surface (0.5 mul/site) to cover the hindlimb region. Animals were then sacrificed 2 weeks later to allow sufficient time for axonal transport of BDA in corticospinal tract. The spinal cords were removed and postfixed at 3 days in cold 4% paraformaldehyde in 0.1 M PBS (pH 7.2). Transverse sections (30 mum) of spinal cord at the injury site and neighboring rostral and caudal parts to the injury site were processed for the presence of BDA-labeled axons by incubation in avidin-HRP (Molecular Probes). Lastly, DAB stain was performed to visualize the positive fiber, as brown color staining.
###end p 27
###begin title 28
GDNF antibody neutralization
###end title 28
###begin p 29
###xml 19 22 <span type="species:ncbi:10116">rat</span>
###xml 256 260 <span type="species:ncbi:10116">rats</span>
After 14 dpo, each rat was intraperitoneally injected with 0.5 ml (30 mg/ml, 30 mg of anti-GDNF diluted in 1 ml of distilled water) anti-GDNF solution once every 2 days until 21 dpo. GDNF antibody was the distilled water replace as control in another five rats. The locomotion in hindlimbs by BBB score was evaluated at 3, 7, 14, and 21 dpo.
###end p 29
###begin title 30
Statistical analysis
###end title 30
###begin p 31
###xml 171 172 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
All data were expressed as the mean +/- S.E.M. They were analyzed using One-way ANOVA and LSD-q test by SPSS software package. The statistical significance was defined as P < 0.05.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
Behavior tests
###end title 33
###begin p 34
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 361 368 361 368 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 368 434 368 432 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">Mean values of BBB scores in cord transected rats (mean&#160;&#177;&#160;S.E.M)</p>
###xml 368 434 368 432 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">Mean values of BBB scores in cord transected rats (mean&#160;&#177;&#160;S.E.M)</p></caption>
###xml 434 439 432 437 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Group</th>
###xml 439 445 437 443 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3&#160;Days</th>
###xml 445 451 443 449 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">7&#160;Days</th>
###xml 451 458 449 456 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14&#160;Days</th>
###xml 458 465 456 463 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">21&#160;Days</th>
###xml 434 465 432 463 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Group</th><th align="left">3&#160;Days</th><th align="left">7&#160;Days</th><th align="left">14&#160;Days</th><th align="left">21&#160;Days</th></tr>
###xml 434 465 432 463 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Group</th><th align="left">3&#160;Days</th><th align="left">7&#160;Days</th><th align="left">14&#160;Days</th><th align="left">21&#160;Days</th></tr></thead>
###xml 465 485 463 483 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Sham-operation group</td>
###xml 485 494 483 490 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">5&#160;&#177;&#160;0.6</td>
###xml 494 502 490 496 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">21&#160;&#177;&#160;0</td>
###xml 502 510 496 502 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">21&#160;&#177;&#160;0</td>
###xml 510 518 502 508 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">21&#160;&#177;&#160;0</td>
###xml 465 518 463 508 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Sham-operation group</td><td char="&#177;" align="char">5&#160;&#177;&#160;0.6</td><td char="&#177;" align="char">21&#160;&#177;&#160;0</td><td char="&#177;" align="char">21&#160;&#177;&#160;0</td><td char="&#177;" align="char">21&#160;&#177;&#160;0</td></tr>
###xml 518 535 508 525 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Transection group</td>
###xml 535 542 525 530 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0&#160;&#177;&#160;0</td>
###xml 542 553 530 539 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.8&#160;&#177;&#160;0.3</td>
###xml 553 564 539 548 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">2.4&#160;&#177;&#160;0.7</td>
###xml 564 575 548 557 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">3.6&#160;&#177;&#160;0.5</td>
###xml 518 575 508 557 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Transection group</td><td char="&#177;" align="char">0&#160;&#177;&#160;0</td><td char="&#177;" align="char">0.8&#160;&#177;&#160;0.3</td><td char="&#177;" align="char">2.4&#160;&#177;&#160;0.7</td><td char="&#177;" align="char">3.6&#160;&#177;&#160;0.5</td></tr>
###xml 575 596 557 578 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Distilled water group</td>
###xml 596 603 578 583 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0&#160;&#177;&#160;0</td>
###xml 603 614 583 592 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.6&#160;&#177;&#160;0.7</td>
###xml 614 625 592 601 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">2.0&#160;&#177;&#160;0.4</td>
###xml 625 636 601 610 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">3.3&#160;&#177;&#160;0.3</td>
###xml 575 636 557 610 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Distilled water group</td><td char="&#177;" align="char">0&#160;&#177;&#160;0</td><td char="&#177;" align="char">0.6&#160;&#177;&#160;0.7</td><td char="&#177;" align="char">2.0&#160;&#177;&#160;0.4</td><td char="&#177;" align="char">3.3&#160;&#177;&#160;0.3</td></tr>
###xml 636 663 610 637 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">GDNF-antibody treated group</td>
###xml 663 670 637 642 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0&#160;&#177;&#160;0</td>
###xml 670 681 642 651 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.2&#160;&#177;&#160;0.4</td>
###xml 681 692 651 660 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.6&#160;&#177;&#160;0.3</td>
###xml 692 703 660 669 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.9&#160;&#177;&#160;0.5</td>
###xml 636 703 610 669 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">GDNF-antibody treated group</td><td char="&#177;" align="char">0&#160;&#177;&#160;0</td><td char="&#177;" align="char">0.2&#160;&#177;&#160;0.4</td><td char="&#177;" align="char">0.6&#160;&#177;&#160;0.3</td><td char="&#177;" align="char">0.9&#160;&#177;&#160;0.5</td></tr>
###xml 465 703 463 669 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Sham-operation group</td><td char="&#177;" align="char">5&#160;&#177;&#160;0.6</td><td char="&#177;" align="char">21&#160;&#177;&#160;0</td><td char="&#177;" align="char">21&#160;&#177;&#160;0</td><td char="&#177;" align="char">21&#160;&#177;&#160;0</td></tr><tr><td align="left">Transection group</td><td char="&#177;" align="char">0&#160;&#177;&#160;0</td><td char="&#177;" align="char">0.8&#160;&#177;&#160;0.3</td><td char="&#177;" align="char">2.4&#160;&#177;&#160;0.7</td><td char="&#177;" align="char">3.6&#160;&#177;&#160;0.5</td></tr><tr><td align="left">Distilled water group</td><td char="&#177;" align="char">0&#160;&#177;&#160;0</td><td char="&#177;" align="char">0.6&#160;&#177;&#160;0.7</td><td char="&#177;" align="char">2.0&#160;&#177;&#160;0.4</td><td char="&#177;" align="char">3.3&#160;&#177;&#160;0.3</td></tr><tr><td align="left">GDNF-antibody treated group</td><td char="&#177;" align="char">0&#160;&#177;&#160;0</td><td char="&#177;" align="char">0.2&#160;&#177;&#160;0.4</td><td char="&#177;" align="char">0.6&#160;&#177;&#160;0.3</td><td char="&#177;" align="char">0.9&#160;&#177;&#160;0.5</td></tr></tbody>
###xml 434 703 432 669 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Group</th><th align="left">3&#160;Days</th><th align="left">7&#160;Days</th><th align="left">14&#160;Days</th><th align="left">21&#160;Days</th></tr></thead><tbody><tr><td align="left">Sham-operation group</td><td char="&#177;" align="char">5&#160;&#177;&#160;0.6</td><td char="&#177;" align="char">21&#160;&#177;&#160;0</td><td char="&#177;" align="char">21&#160;&#177;&#160;0</td><td char="&#177;" align="char">21&#160;&#177;&#160;0</td></tr><tr><td align="left">Transection group</td><td char="&#177;" align="char">0&#160;&#177;&#160;0</td><td char="&#177;" align="char">0.8&#160;&#177;&#160;0.3</td><td char="&#177;" align="char">2.4&#160;&#177;&#160;0.7</td><td char="&#177;" align="char">3.6&#160;&#177;&#160;0.5</td></tr><tr><td align="left">Distilled water group</td><td char="&#177;" align="char">0&#160;&#177;&#160;0</td><td char="&#177;" align="char">0.6&#160;&#177;&#160;0.7</td><td char="&#177;" align="char">2.0&#160;&#177;&#160;0.4</td><td char="&#177;" align="char">3.3&#160;&#177;&#160;0.3</td></tr><tr><td align="left">GDNF-antibody treated group</td><td char="&#177;" align="char">0&#160;&#177;&#160;0</td><td char="&#177;" align="char">0.2&#160;&#177;&#160;0.4</td><td char="&#177;" align="char">0.6&#160;&#177;&#160;0.3</td><td char="&#177;" align="char">0.9&#160;&#177;&#160;0.5</td></tr></tbody></table>
###xml 864 865 830 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 984 985 950 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1082 1083 1048 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 703 1091 669 1057 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36">BBB score in rats subjected to the sham operation was constant. Following transection injury, the BBB score of animals increased significantly from 7 to 21&#160;dpo (<italic>P</italic>&#160;&lt;&#160;0.05). There had no statistical significance in BBB score between cord transection group and distilled water group (<italic>P</italic>&#160;&gt;&#160;0.05), while a significant decrease of BBB score in GDNF-antibody treated group was observed (<italic>P</italic>&#160;&lt;&#160;0.05)</p>
###xml 703 1091 669 1057 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36">BBB score in rats subjected to the sham operation was constant. Following transection injury, the BBB score of animals increased significantly from 7 to 21&#160;dpo (<italic>P</italic>&#160;&lt;&#160;0.05). There had no statistical significance in BBB score between cord transection group and distilled water group (<italic>P</italic>&#160;&gt;&#160;0.05), while a significant decrease of BBB score in GDNF-antibody treated group was observed (<italic>P</italic>&#160;&lt;&#160;0.05)</p></table-wrap-foot>
###xml 361 1091 361 1057 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="35">Mean values of BBB scores in cord transected rats (mean&#160;&#177;&#160;S.E.M)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Group</th><th align="left">3&#160;Days</th><th align="left">7&#160;Days</th><th align="left">14&#160;Days</th><th align="left">21&#160;Days</th></tr></thead><tbody><tr><td align="left">Sham-operation group</td><td char="&#177;" align="char">5&#160;&#177;&#160;0.6</td><td char="&#177;" align="char">21&#160;&#177;&#160;0</td><td char="&#177;" align="char">21&#160;&#177;&#160;0</td><td char="&#177;" align="char">21&#160;&#177;&#160;0</td></tr><tr><td align="left">Transection group</td><td char="&#177;" align="char">0&#160;&#177;&#160;0</td><td char="&#177;" align="char">0.8&#160;&#177;&#160;0.3</td><td char="&#177;" align="char">2.4&#160;&#177;&#160;0.7</td><td char="&#177;" align="char">3.6&#160;&#177;&#160;0.5</td></tr><tr><td align="left">Distilled water group</td><td char="&#177;" align="char">0&#160;&#177;&#160;0</td><td char="&#177;" align="char">0.6&#160;&#177;&#160;0.7</td><td char="&#177;" align="char">2.0&#160;&#177;&#160;0.4</td><td char="&#177;" align="char">3.3&#160;&#177;&#160;0.3</td></tr><tr><td align="left">GDNF-antibody treated group</td><td char="&#177;" align="char">0&#160;&#177;&#160;0</td><td char="&#177;" align="char">0.2&#160;&#177;&#160;0.4</td><td char="&#177;" align="char">0.6&#160;&#177;&#160;0.3</td><td char="&#177;" align="char">0.9&#160;&#177;&#160;0.5</td></tr></tbody></table><table-wrap-foot><p textid="36">BBB score in rats subjected to the sham operation was constant. Following transection injury, the BBB score of animals increased significantly from 7 to 21&#160;dpo (<italic>P</italic>&#160;&lt;&#160;0.05). There had no statistical significance in BBB score between cord transection group and distilled water group (<italic>P</italic>&#160;&gt;&#160;0.05), while a significant decrease of BBB score in GDNF-antibody treated group was observed (<italic>P</italic>&#160;&lt;&#160;0.05)</p></table-wrap-foot></table-wrap>
###xml 54 58 <span type="species:ncbi:10116">rats</span>
###xml 413 417 <span type="species:ncbi:10116">rats</span>
###xml 716 720 <span type="species:ncbi:10116">rats</span>
The BBB score for locomotor function in sham-operated rats hindlimbs was 21. Compared with the sham-operation group, the BBB score of animals in the group with only the cord transection and distilled water group increased gradually from 7 to 21 dpo. A significant decrease in the BBB score for the GDNF-antibody treated group was observed (P < 0.05) (Table 1). Table 1Mean values of BBB scores in cord transected rats (mean +/- S.E.M)Group3 Days7 Days14 Days21 DaysSham-operation group5 +/- 0.621 +/- 021 +/- 021 +/- 0Transection group0 +/- 00.8 +/- 0.32.4 +/- 0.73.6 +/- 0.5Distilled water group0 +/- 00.6 +/- 0.72.0 +/- 0.43.3 +/- 0.3GDNF-antibody treated group0 +/- 00.2 +/- 0.40.6 +/- 0.30.9 +/- 0.5BBB score in rats subjected to the sham operation was constant. Following transection injury, the BBB score of animals increased significantly from 7 to 21 dpo (P < 0.05). There had no statistical significance in BBB score between cord transection group and distilled water group (P > 0.05), while a significant decrease of BBB score in GDNF-antibody treated group was observed (P < 0.05)
###end p 34
###begin p 35
###xml 45 49 <span type="species:ncbi:10116">rats</span>
Mean values of BBB scores in cord transected rats (mean +/- S.E.M)
###end p 35
###begin p 36
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 379 380 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 13 17 <span type="species:ncbi:10116">rats</span>
BBB score in rats subjected to the sham operation was constant. Following transection injury, the BBB score of animals increased significantly from 7 to 21 dpo (P < 0.05). There had no statistical significance in BBB score between cord transection group and distilled water group (P > 0.05), while a significant decrease of BBB score in GDNF-antibody treated group was observed (P < 0.05)
###end p 36
###begin title 37
Somatosensory evoked potentials (SEP)
###end title 37
###begin p 38
###xml 320 321 320 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 322 323 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 324 326 324 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 486 492 486 492 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 559 560 559 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 561 562 561 562 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 563 565 563 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 593 595 593 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 616 618 614 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 639 640 635 636 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 673 675 667 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 693 695 685 687 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 713 715 703 705 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 492 731 492 719 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39">Somatosensory evoked potential was recorded in normal adult rats (P<sub>1</sub>N<sub>1</sub>P<sub>2 </sub>type). The latency of SEP: P<sub>1 </sub>(10.3&#160;&#177;&#160;0.26)&#160;ms, N<sub>1 </sub>(8.81&#160;&#177;&#160;0.34)&#160;ms, P<sub>2</sub> (15.5&#160;&#177;&#160;0.43)&#160;ms, amplitude: P<sub>1 </sub>(2.34&#160;&#177;&#160;0.02), N<sub>1 </sub>(16.3&#160;&#177;&#160;0.14), P<sub>2 </sub>(&#8722;5.06&#160;&#177;&#160;0.05)</p>
###xml 492 731 492 719 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39">Somatosensory evoked potential was recorded in normal adult rats (P<sub>1</sub>N<sub>1</sub>P<sub>2 </sub>type). The latency of SEP: P<sub>1 </sub>(10.3&#160;&#177;&#160;0.26)&#160;ms, N<sub>1 </sub>(8.81&#160;&#177;&#160;0.34)&#160;ms, P<sub>2</sub> (15.5&#160;&#177;&#160;0.43)&#160;ms, amplitude: P<sub>1 </sub>(2.34&#160;&#177;&#160;0.02), N<sub>1 </sub>(16.3&#160;&#177;&#160;0.14), P<sub>2 </sub>(&#8722;5.06&#160;&#177;&#160;0.05)</p></caption>
###xml 731 731 719 719 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11064_2007_9536_Fig1_HTML" id="MO1"/>
###xml 486 731 486 719 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="39">Somatosensory evoked potential was recorded in normal adult rats (P<sub>1</sub>N<sub>1</sub>P<sub>2 </sub>type). The latency of SEP: P<sub>1 </sub>(10.3&#160;&#177;&#160;0.26)&#160;ms, N<sub>1 </sub>(8.81&#160;&#177;&#160;0.34)&#160;ms, P<sub>2</sub> (15.5&#160;&#177;&#160;0.43)&#160;ms, amplitude: P<sub>1 </sub>(2.34&#160;&#177;&#160;0.02), N<sub>1 </sub>(16.3&#160;&#177;&#160;0.14), P<sub>2 </sub>(&#8722;5.06&#160;&#177;&#160;0.05)</p></caption><graphic position="anchor" xlink:href="11064_2007_9536_Fig1_HTML" id="MO1"/></fig>
###xml 360 364 <span type="species:ncbi:10116">rats</span>
###xml 450 454 <span type="species:ncbi:10116">rats</span>
###xml 552 556 <span type="species:ncbi:10116">rats</span>
Evoked potentials are the electrical signals generated by the nervous system in response to sensory stimuli. Somatosensory evoked potentials consist of a series of waves that reflect sequential activation of neural structures along the somatosensory pathways following electrical stimulation of peripheral nerves. SEP (P1N1P2 type) was recorded in the control rats and shown in Fig. 1. Throughout the experimental period, no SEP could be recorded in rats subjected to cord transection. Fig. 1Somatosensory evoked potential was recorded in normal adult rats (P1N1P2 type). The latency of SEP: P1 (10.3 +/- 0.26) ms, N1 (8.81 +/- 0.34) ms, P2 (15.5 +/- 0.43) ms, amplitude: P1 (2.34 +/- 0.02), N1 (16.3 +/- 0.14), P2 (-5.06 +/- 0.05)
###end p 38
###begin p 39
###xml 67 68 67 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 69 70 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 71 73 71 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 101 103 101 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 124 126 122 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 147 148 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 181 183 175 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 201 203 193 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 221 223 211 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 60 64 <span type="species:ncbi:10116">rats</span>
Somatosensory evoked potential was recorded in normal adult rats (P1N1P2 type). The latency of SEP: P1 (10.3 +/- 0.26) ms, N1 (8.81 +/- 0.34) ms, P2 (15.5 +/- 0.43) ms, amplitude: P1 (2.34 +/- 0.02), N1 (16.3 +/- 0.14), P2 (-5.06 +/- 0.05)
###end p 39
###begin title 40
The GDNF immunostained intensity changes
###end title 40
###begin p 41
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 364 365 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 460 466 460 466 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 547 548 547 548 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 636 637 636 637 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 466 638 466 638 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42">In the negative control group, no specific immunopositive staining was detected (<bold>a</bold>). GDNF positive profiles, simultaneously label-GFAP, were present in the white matter (<bold>b</bold>)</p>
###xml 466 638 466 638 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42">In the negative control group, no specific immunopositive staining was detected (<bold>a</bold>). GDNF positive profiles, simultaneously label-GFAP, were present in the white matter (<bold>b</bold>)</p></caption>
###xml 638 638 638 638 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11064_2007_9536_Fig2_HTML" id="MO2"/>
###xml 460 638 460 638 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="42">In the negative control group, no specific immunopositive staining was detected (<bold>a</bold>). GDNF positive profiles, simultaneously label-GFAP, were present in the white matter (<bold>b</bold>)</p></caption><graphic position="anchor" xlink:href="11064_2007_9536_Fig2_HTML" id="MO2"/></fig>
In the control group, GDNF immunoreactivity was observed in the cytoplasm and nuclei of the neurons from the ventral horn in the gray matter (Fig. 3a). Most of the small and medium-sized neurons in the intermediate zone and dorsal horn were stained faintly. GDNF positive profiles (Fig. 3b) simultaneously labeled with GFAP, were present in the white matter (Fig. 2b). In the negative control group, no specific immunopositive staining was detected (Fig. 2a). Fig. 2In the negative control group, no specific immunopositive staining was detected (a). GDNF positive profiles, simultaneously label-GFAP, were present in the white matter (b)
###end p 41
###begin p 42
###xml 81 82 81 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 170 171 170 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
In the negative control group, no specific immunopositive staining was detected (a). GDNF positive profiles, simultaneously label-GFAP, were present in the white matter (b)
###end p 42
###begin p 43
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 225 226 225 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 340 341 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 360 366 360 366 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 520 521 520 521 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 586 587 586 587 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 696 697 696 697 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 699 700 699 700 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 783 785 783 785 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g,</bold>
###xml 893 900 893 900 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d, f, h</bold>
###xml 366 915 366 915 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44">Under higher magnification (400&#215;), GDNF immunoreactivity (IR) was observed in neurons from the ventral horn of the gray matter in the normal spinal cord (<bold>a</bold>, arrow). GDNF (IR) in astrocytes was also seen in white matter (<bold>b</bold>, arrow). In the rostral stump, strong GDNF IR was detected in neurons from the ventral horn at 3 and 7&#160;dpo (<bold>c</bold>, <bold>e</bold>, 400&#215;, arrows). Moderate to intense immunostained neurons were labeled at 14 dpo (<bold>g,</bold> 400&#215;, arrow). Intensely immunostained IR in astrocytes of the white matter were observed from 3 to 14&#160;dpo (<bold>d, f, h</bold>, 400&#215;, arrows)</p>
###xml 366 915 366 915 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44">Under higher magnification (400&#215;), GDNF immunoreactivity (IR) was observed in neurons from the ventral horn of the gray matter in the normal spinal cord (<bold>a</bold>, arrow). GDNF (IR) in astrocytes was also seen in white matter (<bold>b</bold>, arrow). In the rostral stump, strong GDNF IR was detected in neurons from the ventral horn at 3 and 7&#160;dpo (<bold>c</bold>, <bold>e</bold>, 400&#215;, arrows). Moderate to intense immunostained neurons were labeled at 14 dpo (<bold>g,</bold> 400&#215;, arrow). Intensely immunostained IR in astrocytes of the white matter were observed from 3 to 14&#160;dpo (<bold>d, f, h</bold>, 400&#215;, arrows)</p></caption>
###xml 915 915 915 915 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11064_2007_9536_Fig3_HTML" id="MO3"/>
###xml 360 915 360 915 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="44">Under higher magnification (400&#215;), GDNF immunoreactivity (IR) was observed in neurons from the ventral horn of the gray matter in the normal spinal cord (<bold>a</bold>, arrow). GDNF (IR) in astrocytes was also seen in white matter (<bold>b</bold>, arrow). In the rostral stump, strong GDNF IR was detected in neurons from the ventral horn at 3 and 7&#160;dpo (<bold>c</bold>, <bold>e</bold>, 400&#215;, arrows). Moderate to intense immunostained neurons were labeled at 14 dpo (<bold>g,</bold> 400&#215;, arrow). Intensely immunostained IR in astrocytes of the white matter were observed from 3 to 14&#160;dpo (<bold>d, f, h</bold>, 400&#215;, arrows)</p></caption><graphic position="anchor" xlink:href="11064_2007_9536_Fig3_HTML" id="MO3"/></fig>
###xml 915 922 915 922 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 922 977 922 977 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="45">GDNF immunostaining intensity in neurons and astrocytes</p>
###xml 922 977 922 977 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="45">GDNF immunostaining intensity in neurons and astrocytes</p></caption>
###xml 977 977 977 977 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 977 977 977 977 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 977 984 977 984 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Normal </th>
###xml 984 990 984 990 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3&#160;Days</th>
###xml 990 996 990 996 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">7&#160;Days</th>
###xml 996 1003 996 1003 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14&#160;Days</th>
###xml 1003 1011 1003 1011 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">21 &#160;Days</th>
###xml 977 1011 977 1011 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left"/><th align="left">Normal </th><th align="left">3&#160;Days</th><th align="left">7&#160;Days</th><th align="left">14&#160;Days</th><th align="left">21 &#160;Days</th></tr>
###xml 977 1011 977 1011 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"/><th align="left"/><th align="left">Normal </th><th align="left">3&#160;Days</th><th align="left">7&#160;Days</th><th align="left">14&#160;Days</th><th align="left">21 &#160;Days</th></tr></thead>
###xml 1011 1011 1011 1011 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1011 1018 1011 1018 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Neurons</td>
###xml 1018 1019 1018 1019 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 1019 1022 1019 1022 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+++</td>
###xml 1022 1025 1022 1025 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+++</td>
###xml 1025 1043 1025 1031 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">++&#8764;+++</td>
###xml 1043 1061 1031 1037 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">++&#8764;+++</td>
###xml 1011 1061 1011 1037 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"/><td align="left">Neurons</td><td align="left">+</td><td align="left">+++</td><td align="left">+++</td><td align="left">++&#8764;+++</td><td align="left">++&#8764;+++</td></tr>
###xml 1061 1074 1037 1050 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Rostral part </td>
###xml 1074 1085 1050 1061 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Astrocytes </td>
###xml 1085 1087 1061 1063 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">++</td>
###xml 1087 1090 1063 1066 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+++</td>
###xml 1090 1093 1066 1069 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+++</td>
###xml 1093 1096 1069 1072 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+++</td>
###xml 1096 1099 1072 1075 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+++</td>
###xml 1061 1099 1037 1075 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Rostral part </td><td align="left">Astrocytes </td><td align="left">++</td><td align="left">+++</td><td align="left">+++</td><td align="left">+++</td><td align="left">+++</td></tr>
###xml 1099 1111 1075 1087 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Caudal part </td>
###xml 1111 1118 1087 1094 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Neurons</td>
###xml 1118 1119 1094 1095 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+</td>
###xml 1119 1135 1095 1099 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+&#8764;++</td>
###xml 1135 1137 1099 1101 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">++</td>
###xml 1137 1140 1101 1104 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+++</td>
###xml 1140 1142 1104 1106 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">++</td>
###xml 1099 1142 1075 1106 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Caudal part </td><td align="left">Neurons</td><td align="left">+</td><td align="left">+&#8764;++</td><td align="left">++</td><td align="left">+++</td><td align="left">++</td></tr>
###xml 1142 1142 1106 1106 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1142 1152 1106 1116 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Astrocytes</td>
###xml 1152 1154 1116 1118 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">++</td>
###xml 1154 1156 1118 1120 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">++</td>
###xml 1156 1158 1120 1122 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">++</td>
###xml 1158 1161 1122 1125 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+++</td>
###xml 1161 1164 1125 1128 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+++</td>
###xml 1142 1164 1106 1128 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"/><td align="left">Astrocytes</td><td align="left">++</td><td align="left">++</td><td align="left">++</td><td align="left">+++</td><td align="left">+++</td></tr>
###xml 1011 1164 1011 1128 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left"/><td align="left">Neurons</td><td align="left">+</td><td align="left">+++</td><td align="left">+++</td><td align="left">++&#8764;+++</td><td align="left">++&#8764;+++</td></tr><tr><td align="left">Rostral part </td><td align="left">Astrocytes </td><td align="left">++</td><td align="left">+++</td><td align="left">+++</td><td align="left">+++</td><td align="left">+++</td></tr><tr><td align="left">Caudal part </td><td align="left">Neurons</td><td align="left">+</td><td align="left">+&#8764;++</td><td align="left">++</td><td align="left">+++</td><td align="left">++</td></tr><tr><td align="left"/><td align="left">Astrocytes</td><td align="left">++</td><td align="left">++</td><td align="left">++</td><td align="left">+++</td><td align="left">+++</td></tr></tbody>
###xml 977 1164 977 1128 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"/><th align="left">Normal </th><th align="left">3&#160;Days</th><th align="left">7&#160;Days</th><th align="left">14&#160;Days</th><th align="left">21 &#160;Days</th></tr></thead><tbody><tr><td align="left"/><td align="left">Neurons</td><td align="left">+</td><td align="left">+++</td><td align="left">+++</td><td align="left">++&#8764;+++</td><td align="left">++&#8764;+++</td></tr><tr><td align="left">Rostral part </td><td align="left">Astrocytes </td><td align="left">++</td><td align="left">+++</td><td align="left">+++</td><td align="left">+++</td><td align="left">+++</td></tr><tr><td align="left">Caudal part </td><td align="left">Neurons</td><td align="left">+</td><td align="left">+&#8764;++</td><td align="left">++</td><td align="left">+++</td><td align="left">++</td></tr><tr><td align="left"/><td align="left">Astrocytes</td><td align="left">++</td><td align="left">++</td><td align="left">++</td><td align="left">+++</td><td align="left">+++</td></tr></tbody></table>
###xml 1164 1206 1128 1170 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46">Intensity: + weak, ++ moderate, +++ strong</p>
###xml 1206 1465 1170 1429 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="47">Neurons in the ventral horn of the rostral stump was strongly stained for GDNF at 3 and 7&#160;dpo, and in the caudal stump at 14&#160;dpo. The GDNF positive staining in astrocytes was also stronger at all time-points after transection injury than seen in control group</p>
###xml 1164 1465 1128 1429 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="46">Intensity: + weak, ++ moderate, +++ strong</p><p textid="47">Neurons in the ventral horn of the rostral stump was strongly stained for GDNF at 3 and 7&#160;dpo, and in the caudal stump at 14&#160;dpo. The GDNF positive staining in astrocytes was also stronger at all time-points after transection injury than seen in control group</p></table-wrap-foot>
###xml 915 1465 915 1429 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="45">GDNF immunostaining intensity in neurons and astrocytes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"/><th align="left">Normal </th><th align="left">3&#160;Days</th><th align="left">7&#160;Days</th><th align="left">14&#160;Days</th><th align="left">21 &#160;Days</th></tr></thead><tbody><tr><td align="left"/><td align="left">Neurons</td><td align="left">+</td><td align="left">+++</td><td align="left">+++</td><td align="left">++&#8764;+++</td><td align="left">++&#8764;+++</td></tr><tr><td align="left">Rostral part </td><td align="left">Astrocytes </td><td align="left">++</td><td align="left">+++</td><td align="left">+++</td><td align="left">+++</td><td align="left">+++</td></tr><tr><td align="left">Caudal part </td><td align="left">Neurons</td><td align="left">+</td><td align="left">+&#8764;++</td><td align="left">++</td><td align="left">+++</td><td align="left">++</td></tr><tr><td align="left"/><td align="left">Astrocytes</td><td align="left">++</td><td align="left">++</td><td align="left">++</td><td align="left">+++</td><td align="left">+++</td></tr></tbody></table><table-wrap-foot><p textid="46">Intensity: + weak, ++ moderate, +++ strong</p><p textid="47">Neurons in the ventral horn of the rostral stump was strongly stained for GDNF at 3 and 7&#160;dpo, and in the caudal stump at 14&#160;dpo. The GDNF positive staining in astrocytes was also stronger at all time-points after transection injury than seen in control group</p></table-wrap-foot></table-wrap>
###xml 1465 1471 1429 1435 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 1559 1560 1523 1524 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1667 1668 1631 1632 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1788 1789 1752 1753 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1791 1792 1755 1756 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1877 1878 1841 1842 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 2011 2012 1975 1976 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 2116 2117 2080 2081 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 2119 2120 2083 2084 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 1471 2135 1435 2099 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="48">In the rostral stump, moderate to intense immunostained neurons were labeled at 21 dpo (<bold>a</bold>, 400&#215;, arrow). Intensely immunostained IR in astrocytes of the white matter were also observed at 21 dpo (<bold>b</bold>, 400&#215;, arrow). In the caudal stump, immunostained products were detected in neurons of the gray matter at 3 and 7&#160;dpo (<bold>c</bold>, <bold>d</bold>, 400&#215;, arrows). Strong immunostained IR for GDNF in neurons was observed at 14&#160;dpo (<bold>e</bold>, 400&#215;, arrow). Under higher magnification, immunoreactive structures of GDNF were localized in both cytoplasm and nuclei at 21&#160;dpo (<bold>g</bold>, 400&#215;, arrow), GDNF IR in astrocytes of the white matter was intensely immunostained at 14 and 21&#160;dpo (<bold>f</bold>, <bold>h</bold>, 400&#215;, arrows)</p>
###xml 1471 2135 1435 2099 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="48">In the rostral stump, moderate to intense immunostained neurons were labeled at 21 dpo (<bold>a</bold>, 400&#215;, arrow). Intensely immunostained IR in astrocytes of the white matter were also observed at 21 dpo (<bold>b</bold>, 400&#215;, arrow). In the caudal stump, immunostained products were detected in neurons of the gray matter at 3 and 7&#160;dpo (<bold>c</bold>, <bold>d</bold>, 400&#215;, arrows). Strong immunostained IR for GDNF in neurons was observed at 14&#160;dpo (<bold>e</bold>, 400&#215;, arrow). Under higher magnification, immunoreactive structures of GDNF were localized in both cytoplasm and nuclei at 21&#160;dpo (<bold>g</bold>, 400&#215;, arrow), GDNF IR in astrocytes of the white matter was intensely immunostained at 14 and 21&#160;dpo (<bold>f</bold>, <bold>h</bold>, 400&#215;, arrows)</p></caption>
###xml 2135 2135 2099 2099 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11064_2007_9536_Fig4_HTML" id="MO4"/>
###xml 1465 2135 1429 2099 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="48">In the rostral stump, moderate to intense immunostained neurons were labeled at 21 dpo (<bold>a</bold>, 400&#215;, arrow). Intensely immunostained IR in astrocytes of the white matter were also observed at 21 dpo (<bold>b</bold>, 400&#215;, arrow). In the caudal stump, immunostained products were detected in neurons of the gray matter at 3 and 7&#160;dpo (<bold>c</bold>, <bold>d</bold>, 400&#215;, arrows). Strong immunostained IR for GDNF in neurons was observed at 14&#160;dpo (<bold>e</bold>, 400&#215;, arrow). Under higher magnification, immunoreactive structures of GDNF were localized in both cytoplasm and nuclei at 21&#160;dpo (<bold>g</bold>, 400&#215;, arrow), GDNF IR in astrocytes of the white matter was intensely immunostained at 14 and 21&#160;dpo (<bold>f</bold>, <bold>h</bold>, 400&#215;, arrows)</p></caption><graphic position="anchor" xlink:href="11064_2007_9536_Fig4_HTML" id="MO4"/></fig>
In the rostral stump, strong immunostaining for GDNF was observed in neurons from the ventral horn at 3 and 7 dpo (Fig. 3c, d; Table 2). Moderate to intense immunostained neurons were seen at 14 and 21 dpo, as shown in Figs. 3g, 4a and Table 2. In the white matter, astrocytes showed strong immunoreactivity of GDNF from 3 to 21 dpo (Figs. 3d-f, 4b; Table 2). Fig. 3Under higher magnification (400x), GDNF immunoreactivity (IR) was observed in neurons from the ventral horn of the gray matter in the normal spinal cord (a, arrow). GDNF (IR) in astrocytes was also seen in white matter (b, arrow). In the rostral stump, strong GDNF IR was detected in neurons from the ventral horn at 3 and 7 dpo (c, e, 400x, arrows). Moderate to intense immunostained neurons were labeled at 14 dpo (g, 400x, arrow). Intensely immunostained IR in astrocytes of the white matter were observed from 3 to 14 dpo (d, f, h, 400x, arrows)Table 2GDNF immunostaining intensity in neurons and astrocytesNormal 3 Days7 Days14 Days21  DaysNeurons+++++++++approximately+++++approximately+++Rostral part Astrocytes ++++++++++++++Caudal part Neurons++approximately+++++++++Astrocytes++++++++++++Intensity: + weak, ++ moderate, +++ strongNeurons in the ventral horn of the rostral stump was strongly stained for GDNF at 3 and 7 dpo, and in the caudal stump at 14 dpo. The GDNF positive staining in astrocytes was also stronger at all time-points after transection injury than seen in control groupFig. 4In the rostral stump, moderate to intense immunostained neurons were labeled at 21 dpo (a, 400x, arrow). Intensely immunostained IR in astrocytes of the white matter were also observed at 21 dpo (b, 400x, arrow). In the caudal stump, immunostained products were detected in neurons of the gray matter at 3 and 7 dpo (c, d, 400x, arrows). Strong immunostained IR for GDNF in neurons was observed at 14 dpo (e, 400x, arrow). Under higher magnification, immunoreactive structures of GDNF were localized in both cytoplasm and nuclei at 21 dpo (g, 400x, arrow), GDNF IR in astrocytes of the white matter was intensely immunostained at 14 and 21 dpo (f, h, 400x, arrows)
###end p 43
###begin p 44
###xml 154 155 154 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 220 221 220 221 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 330 331 330 331 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 333 334 333 334 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 417 419 417 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g,</bold>
###xml 527 534 527 534 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d, f, h</bold>
Under higher magnification (400x), GDNF immunoreactivity (IR) was observed in neurons from the ventral horn of the gray matter in the normal spinal cord (a, arrow). GDNF (IR) in astrocytes was also seen in white matter (b, arrow). In the rostral stump, strong GDNF IR was detected in neurons from the ventral horn at 3 and 7 dpo (c, e, 400x, arrows). Moderate to intense immunostained neurons were labeled at 14 dpo (g, 400x, arrow). Intensely immunostained IR in astrocytes of the white matter were observed from 3 to 14 dpo (d, f, h, 400x, arrows)
###end p 44
###begin p 45
GDNF immunostaining intensity in neurons and astrocytes
###end p 45
###begin p 46
Intensity: + weak, ++ moderate, +++ strong
###end p 46
###begin p 47
Neurons in the ventral horn of the rostral stump was strongly stained for GDNF at 3 and 7 dpo, and in the caudal stump at 14 dpo. The GDNF positive staining in astrocytes was also stronger at all time-points after transection injury than seen in control group
###end p 47
###begin p 48
###xml 88 89 88 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 196 197 196 197 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 317 318 317 318 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 320 321 320 321 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 406 407 406 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 540 541 540 541 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 645 646 645 646 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 648 649 648 649 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
In the rostral stump, moderate to intense immunostained neurons were labeled at 21 dpo (a, 400x, arrow). Intensely immunostained IR in astrocytes of the white matter were also observed at 21 dpo (b, 400x, arrow). In the caudal stump, immunostained products were detected in neurons of the gray matter at 3 and 7 dpo (c, d, 400x, arrows). Strong immunostained IR for GDNF in neurons was observed at 14 dpo (e, 400x, arrow). Under higher magnification, immunoreactive structures of GDNF were localized in both cytoplasm and nuclei at 21 dpo (g, 400x, arrow), GDNF IR in astrocytes of the white matter was intensely immunostained at 14 and 21 dpo (f, h, 400x, arrows)
###end p 48
###begin p 49
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
In the gray matter of the caudal stump, moderately immunostained neurons were detected at 3, 7 and 21 dpo, and more so at 14 dpo (Fig. 4c-e, g; Table 2). The subcellular localization for GDNF was observed both in cytoplasm and nuclei at 21 dpo (Fig. 4g). At both 14 and 21 dpo, astrocytes in the white matter strongly stain with GDNF immunoreactivity as shown in Fig. 4f, h and Table 2.
###end p 49
###begin title 50
###xml 44 48 <span type="species:ncbi:10116">rats</span>
Localization of GDNF mRNA in spinal cord of rats
###end title 50
###begin p 51
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 474 480 474 480 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 628 629 628 629 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 929 930 929 930 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1023 1024 1023 1024 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 480 1033 480 1033 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="52">In the spinal cord of adult rats, GDNF mRNA-positive product were markedly detected in neurons from the lamina III, IV and V and the central canal (<bold>a</bold>). Medium-sized neurons were seen in the field of intermediomedial nucleus and Nucleus dorsalis. In the ventral horn, GDNF mRNA-positive large neurons were also observed in lamina IX. Under higher magnification (200&#215;), positive products with blue and purple staining were localized in the cytoplasm (<bold>b</bold>, arrows), also in white matter scattered glial cells were probe-labeled with light density (<bold>c</bold>, arrows)</p>
###xml 480 1033 480 1033 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="52">In the spinal cord of adult rats, GDNF mRNA-positive product were markedly detected in neurons from the lamina III, IV and V and the central canal (<bold>a</bold>). Medium-sized neurons were seen in the field of intermediomedial nucleus and Nucleus dorsalis. In the ventral horn, GDNF mRNA-positive large neurons were also observed in lamina IX. Under higher magnification (200&#215;), positive products with blue and purple staining were localized in the cytoplasm (<bold>b</bold>, arrows), also in white matter scattered glial cells were probe-labeled with light density (<bold>c</bold>, arrows)</p></caption>
###xml 1033 1033 1033 1033 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11064_2007_9536_Fig5_HTML" id="MO5"/>
###xml 474 1033 474 1033 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="52">In the spinal cord of adult rats, GDNF mRNA-positive product were markedly detected in neurons from the lamina III, IV and V and the central canal (<bold>a</bold>). Medium-sized neurons were seen in the field of intermediomedial nucleus and Nucleus dorsalis. In the ventral horn, GDNF mRNA-positive large neurons were also observed in lamina IX. Under higher magnification (200&#215;), positive products with blue and purple staining were localized in the cytoplasm (<bold>b</bold>, arrows), also in white matter scattered glial cells were probe-labeled with light density (<bold>c</bold>, arrows)</p></caption><graphic position="anchor" xlink:href="11064_2007_9536_Fig5_HTML" id="MO5"/></fig>
###xml 508 512 <span type="species:ncbi:10116">rats</span>
Signals of hybridization for GDNF mRNA were markedly detected in the Central canal and lamina III, IV and V, in which small neurons were moderately NBT/BCIP stained (Fig. 5a). Medium-sized neurons were seen in the field of the intermediomedial nucleus and nucleus dorsalis (Fig. 5a). In the ventral horn, GDNF mRNA-positive large neurons were also observed in lamina IX (Fig. 5b). A few scattered glial cells were probe-labeled with light density in white matter (Fig. 5c). Fig. 5In the spinal cord of adult rats, GDNF mRNA-positive product were markedly detected in neurons from the lamina III, IV and V and the central canal (a). Medium-sized neurons were seen in the field of intermediomedial nucleus and Nucleus dorsalis. In the ventral horn, GDNF mRNA-positive large neurons were also observed in lamina IX. Under higher magnification (200x), positive products with blue and purple staining were localized in the cytoplasm (b, arrows), also in white matter scattered glial cells were probe-labeled with light density (c, arrows)
###end p 51
###begin p 52
###xml 148 149 148 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 449 450 449 450 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 543 544 543 544 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 28 32 <span type="species:ncbi:10116">rats</span>
In the spinal cord of adult rats, GDNF mRNA-positive product were markedly detected in neurons from the lamina III, IV and V and the central canal (a). Medium-sized neurons were seen in the field of intermediomedial nucleus and Nucleus dorsalis. In the ventral horn, GDNF mRNA-positive large neurons were also observed in lamina IX. Under higher magnification (200x), positive products with blue and purple staining were localized in the cytoplasm (b, arrows), also in white matter scattered glial cells were probe-labeled with light density (c, arrows)
###end p 52
###begin title 53
Western blotting
###end title 53
###begin p 54
A single positive band was observed at a molecular weight of about 34,000, which corresponds to the molecular weight of GDNF.
###end p 54
###begin p 55
###xml 106 107 106 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig7" ref-type="fig">7</xref>
###xml 470 471 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 566 567 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 570 571 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig7" ref-type="fig">7</xref>
###xml 574 580 574 580 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;6</label>
###xml 641 642 641 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 726 727 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 897 898 897 898 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 990 991 990 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1087 1088 1087 1088 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 580 1089 580 1089 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="56">In the rostral stump, GDNF protein level increased at 3&#160;dpo (<italic>P</italic>&#160;&lt;&#160;0.05), then reached its lowest point at 7&#160;dpo which was below the control group (<italic>P</italic>&#160;&lt;&#160;0.05), then began to recover at 14&#160;dpo, but it was less than that of normal level. This was followed by a continuous increase higher than the control group at 21&#160;dpo (<bold>a</bold>). In the caudal stump, GDNF protein decreased at 3&#160;dpo, reached its lowest point at 7&#160;dpo (<italic>P</italic>&#160;&lt;&#160;0.05), then started to increase at 14&#160;dpo, but it was lower than the normal level at 21&#160;dpo (<bold>b</bold>)</p>
###xml 580 1089 580 1089 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="56">In the rostral stump, GDNF protein level increased at 3&#160;dpo (<italic>P</italic>&#160;&lt;&#160;0.05), then reached its lowest point at 7&#160;dpo which was below the control group (<italic>P</italic>&#160;&lt;&#160;0.05), then began to recover at 14&#160;dpo, but it was less than that of normal level. This was followed by a continuous increase higher than the control group at 21&#160;dpo (<bold>a</bold>). In the caudal stump, GDNF protein decreased at 3&#160;dpo, reached its lowest point at 7&#160;dpo (<italic>P</italic>&#160;&lt;&#160;0.05), then started to increase at 14&#160;dpo, but it was lower than the normal level at 21&#160;dpo (<bold>b</bold>)</p></caption>
###xml 1089 1089 1089 1089 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11064_2007_9536_Fig6_HTML" id="MO6"/>
###xml 574 1089 574 1089 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig6"><label>Fig.&#160;6</label><caption><p textid="56">In the rostral stump, GDNF protein level increased at 3&#160;dpo (<italic>P</italic>&#160;&lt;&#160;0.05), then reached its lowest point at 7&#160;dpo which was below the control group (<italic>P</italic>&#160;&lt;&#160;0.05), then began to recover at 14&#160;dpo, but it was less than that of normal level. This was followed by a continuous increase higher than the control group at 21&#160;dpo (<bold>a</bold>). In the caudal stump, GDNF protein decreased at 3&#160;dpo, reached its lowest point at 7&#160;dpo (<italic>P</italic>&#160;&lt;&#160;0.05), then started to increase at 14&#160;dpo, but it was lower than the normal level at 21&#160;dpo (<bold>b</bold>)</p></caption><graphic position="anchor" xlink:href="11064_2007_9536_Fig6_HTML" id="MO6"/></fig>
###xml 1089 1095 1089 1095 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;7</label>
###xml 1153 1154 1153 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1340 1341 1340 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1095 1427 1095 1427 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="57">GDNF levels were significantly different from each other (<italic>P</italic>&#160;&lt;&#160;0.05), except for the comparison between the 21&#160;dpo and normal group, as well as the 21 and 3&#160;dpo group in the rostral stump. The groups were significantly different from each other (<italic>P</italic>&#160;&lt;&#160;0.05), except for the comparison between the 3 and 14&#160;dpo group in the caudal stump</p>
###xml 1095 1427 1095 1427 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="57">GDNF levels were significantly different from each other (<italic>P</italic>&#160;&lt;&#160;0.05), except for the comparison between the 21&#160;dpo and normal group, as well as the 21 and 3&#160;dpo group in the rostral stump. The groups were significantly different from each other (<italic>P</italic>&#160;&lt;&#160;0.05), except for the comparison between the 3 and 14&#160;dpo group in the caudal stump</p></caption>
###xml 1427 1427 1427 1427 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11064_2007_9536_Fig7_HTML" id="MO7"/>
###xml 1089 1427 1089 1427 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig7"><label>Fig.&#160;7</label><caption><p textid="57">GDNF levels were significantly different from each other (<italic>P</italic>&#160;&lt;&#160;0.05), except for the comparison between the 21&#160;dpo and normal group, as well as the 21 and 3&#160;dpo group in the rostral stump. The groups were significantly different from each other (<italic>P</italic>&#160;&lt;&#160;0.05), except for the comparison between the 3 and 14&#160;dpo group in the caudal stump</p></caption><graphic position="anchor" xlink:href="11064_2007_9536_Fig7_HTML" id="MO7"/></fig>
In the rostral stump, the level of GDNF protein increased at 3 dpo, when compared with the control group (P < 0.05), then decreased quickly to its lowest level at 7 dpo (P < 0.05) which was less than that of the control level, and then began to increase again at 14 dpo. However, GDNF protein was higher than what was seen in the control group at 21 dpo (Figs. 6a, 7). In the caudal stump, GDNF protein immediately decreased at 3 dpo, reached its lowest level at 7 dpo (P < 0.05), then increased from 14 to 21 dpo, but it did not go back to the control level (Figs. 6b, 7). Fig. 6In the rostral stump, GDNF protein level increased at 3 dpo (P < 0.05), then reached its lowest point at 7 dpo which was below the control group (P < 0.05), then began to recover at 14 dpo, but it was less than that of normal level. This was followed by a continuous increase higher than the control group at 21 dpo (a). In the caudal stump, GDNF protein decreased at 3 dpo, reached its lowest point at 7 dpo (P < 0.05), then started to increase at 14 dpo, but it was lower than the normal level at 21 dpo (b)Fig. 7GDNF levels were significantly different from each other (P < 0.05), except for the comparison between the 21 dpo and normal group, as well as the 21 and 3 dpo group in the rostral stump. The groups were significantly different from each other (P < 0.05), except for the comparison between the 3 and 14 dpo group in the caudal stump
###end p 55
###begin p 56
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 317 318 317 318 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 410 411 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 507 508 507 508 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
In the rostral stump, GDNF protein level increased at 3 dpo (P < 0.05), then reached its lowest point at 7 dpo which was below the control group (P < 0.05), then began to recover at 14 dpo, but it was less than that of normal level. This was followed by a continuous increase higher than the control group at 21 dpo (a). In the caudal stump, GDNF protein decreased at 3 dpo, reached its lowest point at 7 dpo (P < 0.05), then started to increase at 14 dpo, but it was lower than the normal level at 21 dpo (b)
###end p 56
###begin p 57
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
GDNF levels were significantly different from each other (P < 0.05), except for the comparison between the 21 dpo and normal group, as well as the 21 and 3 dpo group in the rostral stump. The groups were significantly different from each other (P < 0.05), except for the comparison between the 3 and 14 dpo group in the caudal stump
###end p 57
###begin title 58
BDA tracing
###end title 58
###begin p 59
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig8" ref-type="fig">8</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig8" ref-type="fig">8</xref>
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig8" ref-type="fig">8</xref>
###xml 226 232 226 232 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;8</label>
###xml 340 341 340 341 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 381 382 381 382 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 432 433 432 433 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 232 434 232 434 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="60">BDA-positive axons staining as brown silkiness were detected in rostral cord sections near the injury site (<bold>a</bold>), but not in the field of scar tissue (<bold>b</bold>), and caudal cord sections near the injury site (<bold>c</bold>)</p>
###xml 232 434 232 434 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="60">BDA-positive axons staining as brown silkiness were detected in rostral cord sections near the injury site (<bold>a</bold>), but not in the field of scar tissue (<bold>b</bold>), and caudal cord sections near the injury site (<bold>c</bold>)</p></caption>
###xml 434 434 434 434 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11064_2007_9536_Fig8_HTML" id="MO8"/>
###xml 226 434 226 434 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig8"><label>Fig.&#160;8</label><caption><p textid="60">BDA-positive axons staining as brown silkiness were detected in rostral cord sections near the injury site (<bold>a</bold>), but not in the field of scar tissue (<bold>b</bold>), and caudal cord sections near the injury site (<bold>c</bold>)</p></caption><graphic position="anchor" xlink:href="11064_2007_9536_Fig8_HTML" id="MO8"/></fig>
BDA-positive axons which stained as brown silkiness were detected in rostral cord sections of the injury site (Fig. 8a), but not in the field of scar tissue (Fig. 8b), and in the caudal segment near the injury site (Fig. 8c). Fig. 8BDA-positive axons staining as brown silkiness were detected in rostral cord sections near the injury site (a), but not in the field of scar tissue (b), and caudal cord sections near the injury site (c)
###end p 59
###begin p 60
###xml 108 109 108 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 149 150 149 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 200 201 200 201 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
BDA-positive axons staining as brown silkiness were detected in rostral cord sections near the injury site (a), but not in the field of scar tissue (b), and caudal cord sections near the injury site (c)
###end p 60
###begin title 61
Discussion
###end title 61
###begin p 62
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 628 632 <span type="species:ncbi:10116">rats</span>
###xml 687 691 <span type="species:ncbi:10116">rats</span>
In the present study, GDNF immunoreactive products in neurons from the gray matter and in astrocytes from the white matter of the spinal cord were observed in the sham-operation group. This indicates that GDNF could be involved in either the physiological function or the maintenance of survival for all kinds of neurons and astrocytes. It has been shown that GDNF mRNAs widely distributed in a variety of neuronal and non-neuronal tissues of embryos and adults [4, 23-25]. In addition, GDNF mRNA positive signals were found in the ventral horns, the field of nucleus dorsalis, and the dorsal horns in the spinal cords of adult rats [2, 16, 27] and in the dorsal root ganglia in newborn rats [23]. Therefore, it raised the possibility that GDNF was synthesized by cells of the spinal cord and the GDNF expression may be changed after lesion, which implies that GDNF plays a potential role in both physiological and pathological conditions.
###end p 62
###begin p 63
###xml 1088 1090 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1092 1094 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 1186 1187 1186 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 1189 1190 1189 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 1192 1194 1192 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 1195 1197 1195 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 1344 1345 1344 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 1347 1349 1347 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1351 1353 1351 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 1355 1357 1355 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 1358 1360 1358 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 28 32 <span type="species:ncbi:10116">rats</span>
###xml 433 437 <span type="species:ncbi:10116">rats</span>
###xml 885 889 <span type="species:ncbi:10116">rats</span>
###xml 1082 1086 <span type="species:ncbi:10116">rats</span>
Following cord transection, rats exhibited spinal cord dysfunction throughout the experimental period. There was an absence of SEP in surface recordings, indicating a loss of sensory function in the hindlimbs following transection injury. Comparatively, locomotion function recovery was observed from 7 to 21 dpo, which was parallel to the improvement in BBB score. It showed that locomotor functional plasticity in the hindlimbs of rats did occur following SCI. As corticospinal tract regeneration was not seen in the caudal part near the injury site and scar tissues, it appears impossible to reestablish connectivity between the areas rostral and caudal of the injury site. The possible reason for locomotor function improvement may be related to the modulation of spinal circuit activity from endogenous neurotrophins. In the present study, BBB scores in the GDNF-antibody treated rats was inferior to that of the group not receiving the antibody treatment, indicating intrinsic GDNF may be available for improving locomotor function recovery to some extent in the hindlimbs of rats [15, 28]. It has been reported that GDNF can promote the repair or survival of spinal motoneurons [4, 7, 29-32]. Several other studies have shown that the administration of GDNF could promote axonal regeneration, and enhance locomotion functional recovery [2, 15, 30, 33-36].
###end p 63
###begin p 64
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 681 683 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">38</xref>
###xml 888 890 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">39</xref>
GDNF immunoreactivity products in neurons from the ventral horn of the rostral stump were strongly stained at 3 and 7 dpo, and in the caudal stump at 14 dpo, suggesting that the GDNF expression in neurons was up-regulated following injury. This may be related to the locomotion functional recovery of hindlimbs. Glazner et al. [37] showed that strong labeling for GDNFR-alpha and c-ret mRNA was observed in large neurons from the ventral horn. Our results also supported the mRNA expression for GDNF in neurons of the ventral horn, as well as astrocytes in white matter using in situ hybridization. RET expression was unregulated following peripheral axotomy in alpha-motoneurons [38], and topical application of GDNF 30 min after SCI significantly improved motor function and reduced blood-spinal cord barrier (BSCB) breakdown, edema formation, and cell injury at 5 h has been reported [39]. Therefore, GDNF is available to assist in locomotion functional plasticity by exerting behavioral and anatomic neuroprotection following SCI.
###end p 64
###begin p 65
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">40</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">41</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
In the present study, the expression patterns of endogenous GDNF indicated its possible role in maintaining motorneuron survival because GDNF mRNA-positive products were detected in neurons from the ventral horn by in situ hybridization. Of course, GDNF retrograde axonal transport from a target tissue to neuronal cell bodies [40, 41] is not absolutely excluded. It has been reported that GDNF produced by skeletal muscle is taken up at the nerve terminals and retrogradely transported to motoneurons of the ventral horn by axons [30].
###end p 65
###begin p 66
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">42</xref>
###xml 1131 1133 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
Comparing the results of immunostaining, the GDNF level varied throughout the spinal cord at 3 dpo. In the caudal stump, GDNF showed a significant decrease. This was probably due to the transection injury that triggers a process destructive to ascending and descending tracts conduction and that extends tissue loss. Differently, a rapid up-regulation of GDNF was observed in the rostral stump. This suggested that GDNF had accumulated around the transection site due to interruption of its transport within the axons. Satake et al. [42] reported GDNF transcription began to increase within 30 min after injury and peaked within 3 h after spinal cord contusion injury. Interestingly, the level of GDNF protein reached its lowest point at 7 dpo in both stumps, probably due to the consequences of cell death or apoptosis and/or interruption of the spinal cord pathways. Subsequently, GDNF protein levels gradually started to recover and surpassed the control level in the rostral stumps at 21 dpo, which may be explained by (1) GDNF transport within axons was strengthened, (2) inflammation leads to the increase of GDNF synthesis [36], and (3) induction of de novo synthesis of GDNF by neurons and/or non-neuronal cells.
###end p 66
###begin p 67
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR43">43</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">44</xref>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 384 387 <span type="species:ncbi:10116">rat</span>
Noticeably, the GDNF positive cells in the white matter were labeled by GFAP simultaneously, which identified the labeled cells as astrocytes. Indeed, an association between reactive astrocytes and regenerating nerve fibers in the white matter of the central nervous system in vivo has been reported [43, 44]. Also, increased GFR-1 in astrocytes of degenerating white matter in adult rat spinal cords after mechanical injury has been shown [2]. These results indicated that GDNF expression in astrocytes may be involved in neuroplasticity following spinal cord transection injury.
###end p 67
###begin p 68
The present study provides new evidence to understand the role of intrinsic GDNF in the rostral and caudal stumps of injured spinal cords. It suggests that GDNF plays an essential role in the neuroplasticity of the local circuitry, especially in the caudal stump of the transected spinal cords.
###end p 68
###begin title 69
Acknowledgements
###end title 69
###begin p 70
We thank Kevin J. Foehrkolb and Yates Lee M.D. for their invaluable comments in the writing of this manuscript.
###end p 70
###begin p 71
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 71
###begin title 72
Reference
###end title 72
###begin article-title 73
Spinal cord injury (SCI) often results in significant neurologic dysfunction and disability. An annual incidence of 15 to 40 traumatic SCI cases per million population has been reported worldwide, and a conservative estimate for Singapore would be 23 cases per million
###end article-title 73
###begin article-title 74
Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid
###end article-title 74
###begin article-title 75
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
###end article-title 75
###begin article-title 76
GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle
###end article-title 76
###begin article-title 77
Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain
###end article-title 77
###begin article-title 78
GDNF is an age-specific survival factor for sensory and autonomic neurons
###end article-title 78
###begin article-title 79
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor
###end article-title 79
###begin article-title 80
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
###end article-title 80
###begin article-title 81
GDNF family neurotrophic factor signaling: four masters, one servant?
###end article-title 81
###begin article-title 82
The GDNF family: signalling, biological functions and therapeutic value
###end article-title 82
###begin article-title 83
###xml 90 94 <span type="species:ncbi:10116">rats</span>
Effects of neurotrophic factors on motoneuron survival following axonal injury in newborn rats
###end article-title 83
###begin article-title 84
Restriction of axonal retraction and promotion of axonal regeneration by chronically injured neurons after intraspinal treatment with glial cell line-derived neurotrophic factor (GDNF)
###end article-title 84
###begin article-title 85
Intraspinal implants of fibrin glue containing glial cell line-derived neurotrophic factor promote dorsal root regeneration into spinal cord
###end article-title 85
###begin article-title 86
A non-invasive transport system for GDNF across the blood-brain barrier
###end article-title 86
###begin article-title 87
###xml 25 28 <span type="species:ncbi:10116">rat</span>
Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor
###end article-title 87
###begin article-title 88
Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination
###end article-title 88
###begin article-title 89
Glial cell line-derived axonal regeneration and enhance myelination after spinal cord injury
###end article-title 89
###begin article-title 90
###xml 12 17 <span type="species:ncbi:9606">human</span>
Role of the human transferrin receptor cytoplasmic domain in endocytosis: localization of a specific signal sequence for internalization
###end article-title 90
###begin article-title 91
Glial cell line-derived neurotrophic factor signaling through the Ret receptor tyrosine kinase
###end article-title 91
###begin article-title 92
Characterization of a multicomponent receptor for GDNF
###end article-title 92
###begin article-title 93
Functional receptor for glial cell line-derived neurotrophic factor encoded by the c-ret proto-oncogene product
###end article-title 93
###begin article-title 94
###xml 49 52 <span type="species:ncbi:10116">rat</span>
Regional and cell-specific expression of GDNF in rat brain
###end article-title 94
###begin article-title 95
###xml 27 30 <span type="species:ncbi:10116">rat</span>
###xml 35 40 <span type="species:ncbi:9606">human</span>
Expression of GDNF mRNA in rat and human nervous tissue
###end article-title 95
###begin article-title 96
Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons
###end article-title 96
###begin article-title 97
Neurturin, a relative of glial-cell-line-derived neurotrophic factor
###end article-title 97
###begin article-title 98
###xml 74 78 <span type="species:ncbi:10116">rats</span>
A sensitive and reliable locomotor rating scale for open field testing in rats
###end article-title 98
###begin article-title 99
Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system
###end article-title 99
###begin article-title 100
Neuroprotection of glial cell line-derived neurotrophic factor in damaged spinal cords following contusive injury
###end article-title 100
###begin article-title 101
Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF
###end article-title 101
###begin article-title 102
In vivo neurotrophic factor of GDNF on neonatal and adult facial motor neurons
###end article-title 102
###begin article-title 103
GDNF: a cytokine at the interface of TGF-betas and neurotrophins
###end article-title 103
###begin article-title 104
###xml 141 145 <span type="species:ncbi:10116">rats</span>
Neurotrophin-4 (NT-4) and glial cell line-derived neurotrophic factor (GDNF) promote the survival of corticospinal motor neurons of neonatal rats in vitro
###end article-title 104
###begin article-title 105
Cationic liposome-mediated GDNF gene transfer after spinal cord injury
###end article-title 105
###begin article-title 106
###xml 152 156 <span type="species:ncbi:10116">rats</span>
Protective effect of liposome mediated glial cell line-derived neurotrophic factor gene transfer in vivo on motoneurons following spinal cord injury in rats
###end article-title 106
###begin article-title 107
Olfactory ensheathing cells genetically modified to secrete GDNF to promote spinal cord repair
###end article-title 107
###begin article-title 108
Inflammation-induced GDNF improves locomotor function after spinal cord injury
###end article-title 108
###begin article-title 109
###xml 93 96 <span type="species:ncbi:10116">rat</span>
Localization of glial cell line-derived neurotrophic factor receptor alpha and c-ret mRNA in rat central nervous system
###end article-title 109
###begin article-title 110
###xml 108 111 <span type="species:ncbi:10116">rat</span>
Post-traumatic application of brain-derived neurotrophic factor and glia-derived neurotrophic factor on the rat spinal cord enhances neuroprotection and improves motor function
###end article-title 110
###begin article-title 111
###xml 163 168 <span type="species:ncbi:10090">mouse</span>
Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis
###end article-title 111
###begin article-title 112
Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases
###end article-title 112
###begin article-title 113
Up-regulation of glial cell line-derived neurotrophic factor (GDNF) following traumatic spinal cord injury
###end article-title 113
###begin article-title 114
Regeneration of adult axons in white matter tracts of the central nervous system
###end article-title 114
###begin article-title 115
###xml 85 88 <span type="species:ncbi:10116">rat</span>
Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord
###end article-title 115
###begin p 116
An erratum to this article can be found at 
###end p 116

